Provided by Tiger Fintech (Singapore) Pte. Ltd.

Rigel Pharmaceuticals

19.84
+0.09500.48%
Post-market: 18.85-0.9850-4.97%17:40 EDT
Volume:204.94K
Turnover:4.00M
Market Cap:354.50M
PE:9.52
High:19.91
Open:19.68
Low:18.97
Close:19.74
Loading ...
Jan 10, 2022

Major Issues Report

8-K - Current report
Dec 17, 2021

Major Issues Report

8-K - Current report
Nov 05, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 05, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 05, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 05, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 10, 2021

Beneficial Ownership Change

RIGEL PHARMACEUTICALS INC
Aug 03, 2021

Major Issues Report

8-K - Current report
Aug 03, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 21, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 21, 2021

Major Issues Report

8-K - Current report
May 14, 2021

Major Issues Report

8-K - Current report
May 05, 2021

Major Issues Report

8-K - Current report
May 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 13, 2021

Major Issues Report

8-K - Current report
Mar 02, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2021

Major Issues Report

8-K - Current report
Feb 18, 2021

Major Issues Report

8-K - Current report
Feb 16, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals